Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2987 | 2093 | 44.4 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
2256 | 2 | CARBONIC ANHYDRASE//CHIM BIOINORGAN//POLO SCI | 4686 |
2987 | 1 | CHIM BIOINORGAN//CARBONIC ANHYDRASE//POLO SCI | 2093 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHIM BIOINORGAN | address | 6756352 | 26% | 85% | 547 |
2 | CARBONIC ANHYDRASE | authKW | 3863008 | 38% | 33% | 795 |
3 | POLO SCI | address | 1566325 | 7% | 70% | 153 |
4 | NEUROFARBA | address | 1259253 | 10% | 42% | 204 |
5 | CARBONIC ANHYDRASE IX | authKW | 1134246 | 6% | 60% | 129 |
6 | SEZ SCI FARMACEUT | address | 1100088 | 4% | 93% | 81 |
7 | SEZ SCI FARMACEUT NUTRACEUT | address | 942751 | 3% | 91% | 71 |
8 | DIPARTIMENTO NEUROFARBA | address | 780131 | 3% | 82% | 65 |
9 | SECT PHARMACEUT NUTRICEUT SCI | address | 718875 | 3% | 93% | 53 |
10 | SULFONAMIDES | authKW | 532617 | 14% | 12% | 293 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 48928 | 45% | 0% | 944 |
2 | Chemistry, Organic | 4833 | 23% | 0% | 474 |
3 | Biochemistry & Molecular Biology | 3501 | 36% | 0% | 751 |
4 | Oncology | 1014 | 13% | 0% | 277 |
5 | Pharmacology & Pharmacy | 200 | 8% | 0% | 175 |
6 | Pathology | 95 | 3% | 0% | 55 |
7 | Biophysics | 83 | 3% | 0% | 72 |
8 | Urology & Nephrology | 60 | 2% | 0% | 49 |
9 | Chemistry, Multidisciplinary | 28 | 6% | 0% | 120 |
10 | Biochemical Research Methods | 20 | 2% | 0% | 43 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHIM BIOINORGAN | 6756352 | 26% | 85% | 547 |
2 | POLO SCI | 1566325 | 7% | 70% | 153 |
3 | NEUROFARBA | 1259253 | 10% | 42% | 204 |
4 | SEZ SCI FARMACEUT | 1100088 | 4% | 93% | 81 |
5 | SEZ SCI FARMACEUT NUTRACEUT | 942751 | 3% | 91% | 71 |
6 | DIPARTIMENTO NEUROFARBA | 780131 | 3% | 82% | 65 |
7 | SECT PHARMACEUT NUTRICEUT SCI | 718875 | 3% | 93% | 53 |
8 | CHIM INORGAN BIOINORGAN | 368976 | 3% | 39% | 65 |
9 | CHIM BIOORGAN | 344174 | 6% | 18% | 128 |
10 | IST BIOSCI BIORISORSE | 282137 | 2% | 54% | 36 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 407597 | 11% | 12% | 233 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY | 41768 | 9% | 1% | 193 |
3 | JOURNAL OF ENZYME INHIBITION | 29822 | 1% | 8% | 27 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 28702 | 11% | 1% | 223 |
5 | JOURNAL OF MEDICINAL CHEMISTRY | 7800 | 5% | 1% | 108 |
6 | EXPERT OPINION ON THERAPEUTIC PATENTS | 7088 | 2% | 1% | 33 |
7 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 3841 | 2% | 1% | 50 |
8 | CURRENT PHARMACEUTICAL DESIGN | 1550 | 1% | 0% | 26 |
9 | CHEMICAL BIOLOGY & DRUG DESIGN | 1049 | 1% | 1% | 11 |
10 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | 759 | 1% | 0% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARBONIC ANHYDRASE | 3863008 | 38% | 33% | 795 | Search CARBONIC+ANHYDRASE | Search CARBONIC+ANHYDRASE |
2 | CARBONIC ANHYDRASE IX | 1134246 | 6% | 60% | 129 | Search CARBONIC+ANHYDRASE+IX | Search CARBONIC+ANHYDRASE+IX |
3 | SULFONAMIDES | 532617 | 14% | 12% | 293 | Search SULFONAMIDES | Search SULFONAMIDES |
4 | BETA CLASS ENZYME | 364688 | 1% | 100% | 25 | Search BETA+CLASS+ENZYME | Search BETA+CLASS+ENZYME |
5 | CARBONIC ANHYDRASE INHIBITORS | 331575 | 3% | 32% | 72 | Search CARBONIC+ANHYDRASE+INHIBITORS | Search CARBONIC+ANHYDRASE+INHIBITORS |
6 | CA IX | 314360 | 2% | 57% | 38 | Search CA+IX | Search CA+IX |
7 | HYDRATASE ACTIVITY | 261486 | 1% | 81% | 22 | Search HYDRATASE+ACTIVITY | Search HYDRATASE+ACTIVITY |
8 | SULFAMIDE | 260392 | 2% | 54% | 33 | Search SULFAMIDE | Search SULFAMIDE |
9 | BETA CARBONIC ANHYDRASE | 233392 | 1% | 80% | 20 | Search BETA+CARBONIC+ANHYDRASE | Search BETA+CARBONIC+ANHYDRASE |
10 | SULFAMATE | 227844 | 2% | 46% | 34 | Search SULFAMATE | Search SULFAMATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SUPURAN, CT , (2016) HOW MANY CARBONIC ANHYDRASE INHIBITION MECHANISMS EXIST?.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 31. ISSUE 3. P. 345 -360 | 157 | 96% | 6 |
2 | SUPURAN, CT , (2017) ADVANCES IN STRUCTURE-BASED DRUG DISCOVERY OF CARBONIC ANHYDRASE INHIBITORS.EXPERT OPINION ON DRUG DISCOVERY. VOL. 12. ISSUE 1. P. 61 -88 | 173 | 93% | 0 |
3 | SUPURAN, CT , DE SIMONE, G , ALTERIO, V , DI FIORE, A , D'AMBROSIO, K , (2012) MULTIPLE BINDING MODES OF INHIBITORS TO CARBONIC ANHYDRASES: HOW TO DESIGN SPECIFIC DRUGS TARGETING 15 DIFFERENT ISOFORMS?.CHEMICAL REVIEWS. VOL. 112. ISSUE 8. P. 4421 -4468 | 177 | 60% | 103 |
4 | SUPURAN, CT , (2008) CARBONIC ANHYDRASES: NOVEL THERAPEUTIC APPLICATIONS FOR INHIBITORS AND ACTIVATORS.NATURE REVIEWS DRUG DISCOVERY. VOL. 7. ISSUE 2. P. 168 -181 | 87 | 85% | 607 |
5 | PASTOREK, J , PASTOREKOVA, S , (2015) HYPOXIA-INDUCED CARBONIC ANHYDRASE IX AS A TARGET FOR CANCER THERAPY: FROM BIOLOGY TO CLINICAL USE.SEMINARS IN CANCER BIOLOGY. VOL. 31. ISSUE . P. 52 -64 | 122 | 72% | 27 |
6 | MCDONALD, PC , WINUM, JY , SUPURAN, CT , DEDHAR, S , (2012) RECENT DEVELOPMENTS IN TARGETING CARBONIC ANHYDRASE IX FOR CANCER THERAPEUTICS.ONCOTARGET. VOL. 3. ISSUE 1. P. 84-97 | 94 | 88% | 85 |
7 | CAPASSO, C , SUPURAN, CT , (2015) BACTERIAL, FUNGAL AND PROTOZOAN CARBONIC ANHYDRASES AS DRUG TARGETS.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 19. ISSUE 12. P. 1689 -1704 | 123 | 82% | 0 |
8 | PASTOREKOVA, S , ZATOVICOVA, M , PASTOREK, J , (2008) CANCER-ASSOCIATED CARBONIC ANHYDRASES AND THEIR INHIBITION.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 7. P. 685-698 | 132 | 72% | 101 |
9 | LICSANDRU, E , TANC, M , KOCSIS, I , BARBOIU, M , SUPURAN, CT , (2017) A CLASS OF CARBONIC ANHYDRASE I - SELECTIVE ACTIVATORS.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 32. ISSUE 1. P. 37 -46 | 96 | 97% | 0 |
10 | DE SIMONE, G , ALTERIO, V , SUPURAN, CT , (2013) EXPLOITING THE HYDROPHOBIC AND HYDROPHILIC BINDING SITES FOR DESIGNING CARBONIC ANHYDRASE INHIBITORS.EXPERT OPINION ON DRUG DISCOVERY. VOL. 8. ISSUE 7. P. 793 -810 | 96 | 91% | 21 |
Classes with closest relation at Level 1 |